Sign up to save your podcasts
Or
Share Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Semaglutide and the Future of Kidney Disease, with Brendon Neuen, MBBS, PhD
Brendon Neuen, MBBS, PhD, joins hosts to discuss the landmark FLOW trial and its implications on the future of chronic kidney disease management as well as other compelling data surrounding semaglutide from the 61st European Renal Association Congress.
Key Highlights:
00:00 - Intro
01:12 - ERA Recap
03:06 - FLOW Background
05:20 - FLOW Results
06:56 - FLOW Reaction (Neuen)
09:13 - Semaglutide Mortality Benefit
12:43 - Semaglutide 2.4 in CKD
17:30 - Implementation Science
22:30 - Management Approach
View all episodes
By HCPLive Cardiology
5
11 ratings
Brendon Neuen, MBBS, PhD, joins hosts to discuss the landmark FLOW trial and its implications on the future of chronic kidney disease management as well as other compelling data surrounding semaglutide from the 61st European Renal Association Congress.
Key Highlights:
00:00 - Intro
01:12 - ERA Recap
03:06 - FLOW Background
05:20 - FLOW Results
06:56 - FLOW Reaction (Neuen)
09:13 - Semaglutide Mortality Benefit
12:43 - Semaglutide 2.4 in CKD
17:30 - Implementation Science
22:30 - Management Approach
More shows like Don't Miss a Beat
View all
JACC This Week
168 Listeners
This Week in Cardiology
883 Listeners